# Avery Dennison Corp: Form 10-Q for the period ended Apr 2, 2016

- Company: [Avery Dennison Corp](/companies/avy.md) (CIK 8818)
- Form: 10-Q
- Filed: 2016-05-03
- Accepted by EDGAR: May 3, 2016, 16:06 ET
- Period: 2016-04-02
- Accession: 0001104659-16-117169
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/8818/000110465916117169/a16-6174_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/8818/000110465916117169/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-04-02.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-01-03 to 2016-04-02 | $1.49bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2016-01-03 to 2016-04-02 | $1.06bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2016-01-03 to 2016-04-02 | $422.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2016-01-03 to 2016-04-02 | $278.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2016-01-03 to 2016-04-02 | $15.3m | us-gaap:InterestExpense |
| Income tax | 3 months, 2016-01-03 to 2016-04-02 | $33.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-01-03 to 2016-04-02 | $89.6m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2016-01-03 to 2016-04-02 | $0.98 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2016-01-03 to 2016-04-02 | $1.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2016-01-03 to 2016-04-02 | 91,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2016-01-03 to 2016-04-02 | −$6.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2016-01-03 to 2016-04-02 | $25.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2016-01-03 to 2016-04-02 | $33.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2016-01-03 to 2016-04-02 | $95.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2016-04-02 | $169.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-04-02 | $1.89bn | us-gaap:AssetsCurrent |
| Total assets | at 2016-04-02 | $4.25bn | us-gaap:Assets |
| Current liabilities | at 2016-04-02 | $1.59bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | at 2016-04-02 | $264.9m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2016-04-02 | $968.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 30,196 characters.

Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides management’s views on our financial condition and results of operations, should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements and notes thereto, and includes the following sections:

|  |  |
| --- | ---: |
| Non-GAAP Financial Measures | 17 |
| Overview and Outlook | 18 |
| Analysis of Results of Operations for the First Quarter | 20 |
| Results of Operations by Reportable Segment for the First Quarter | 22 |
| Financial Condition | 24 |
| Recent Accounting Requirements | 27 |

### NON-GAAP FINANCIAL MEASURES

We report financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement the presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from our investors and financial analysts, we believe that supplemental non-GAAP financial measures provide information that is useful to the assessment of our performance and operating trends, as well as liquidity. The measures we use may not be comparable to similarly named non-GAAP measures used by other companies.

Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. By excluding the accounting effects, both positive and negative, of certain items, we believe that we are providing meaningful supplemental information to facilitate an understanding of our core operating results and liquidity measures. These non-GAAP financial measures are used internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing.

We use the following non-GAAP financial measures in this MD&A:

- *Organic sales change* refers to the increase or decrease in sales excluding the estimated impact of currency translation, product line exits, acquisitions and divestitures, and, where applicable, the extra week in a fiscal year. The estimated impact of currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations. We believe organic sales change assists investors in evaluating the underlying sales growth from the ongoing activities of our businesses and provides improved comparability of results period to period.
- *Free cash flow* refers to cash flow from operations, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from sales (purchases) of investments. We believe that this non-GAAP financial measure assists investors by showing the amount of cash we have available for discretionary debt reductions, dividends, share repurchases, and acquisitions.
- *Operational working capital* refers to trade accounts receivable and inventories, net of accounts payable, and excludes cash and cash equivalents, short-term borrowings, deferred taxes, other current assets and other current liabilities, as well as current assets and current liabilities of held-for-sale businesses. We use this non-GAAP financial measure to assess our working capital requirements because it excludes the impact of fluctuations attributable to our financing and other activities (which affect cash and cash equivalents, deferred taxes, other current assets, and other current liabilities) that tend to be disparate in amount, frequency, or timing, and that may increase the volatility of working capital as a percentage of sales from period to period. Additionally, the excluded items are not significantly influenced by our day-to-day activities managed at the operating level and do not necessarily reflect the underlying trends in our operations.

### OVERVIEW AND OUTLOOK

### Prior Period Financial Statement Revision

Certain prior period amounts have been revised to reflect the impact of certain adjustments. Refer to Note 2, “Prior Period Financial Statement Revision,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Net Sales

| Estimated change in net sales due to | Three Months Ended April 2, 2016 |
| --- | ---: |
| Organic sales change | 4% |
| Foreign currency translation | (6) |
| Product line divestiture | (1) |
| Reported sales change | (3)% |

In the first quarter of 2016, net sales increased on an organic basis primarily due to higher volume.

### Net Income

Net income increased approximately $18 million in the first quarter of 2016 compared to the same period last year. Major factors affecting net income in the first three months of 2016 included:

Positive factors:

- Benefits from productivity initiatives, including savings from restructuring actions, net of transition costs
- Higher volume
- Lower restructuring charges

Offsetting factors:

- Higher employee-related costs
- Unfavorable geographic mix
- Foreign currency translation

### Cost Reduction Actions

#### 2015/2016 Actions

During the three months ended April 2, 2016, we recorded $5.7 million in restructuring charges related to restructuring actions initiated during the third quarter of 2015 that we expect to continue through 2016 (“2015/2016 Actions”). These charges consisted of severance and related costs for the reduction of approximately 65 positions, lease cancellation costs, and asset impairment charges.

During fiscal year 2015, we recorded $26.1 million in restructuring charges, net of reversals, related to our 2015/2016 Actions. These charges consisted of severance and related costs for the reduction of approximately 430 positions, lease cancellation costs, and asset impairment charges.

No employees impacted by our 2015/2016 Actions taken through April 2, 2016 remained employed with us as of such date. We expect charges and payments related to these actions to be substantially completed in 2016.

#### 2014/2015 Actions

During fiscal year 2015, we recorded $33.4 million in restructuring charges, net of reversals, related to restructuring actions we initiated in 2014 that continued through the second quarter of 2015 (“2014/2015 Actions”). These charges consisted of severance and related costs for the reduction of approximately 605 positions, lease cancellation costs, and asset impairment charges.

Approximately 85 employees impacted by our 2014/2015 Actions remained employed with us as of April 2, 2016. We expect charges and payments related to these actions to be substantially completed in 2016.

#### Impact of Cost Reduction Actions

In 2016, we expect to realize approximately $75 million in savings, net of transition costs, from our 2015/2016 Actions and 2014/2015 Actions. We anticipate carryover savings from these actions in 2017.

Restructuring charges are included in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income. Refer to Note 9, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Pending Acquisition

In April 2016, we entered into an agreement to acquire the European business of MACtac (“MACtac”) from Platinum Equity for a purchase price of €200 million, including assumed debt. The purchase price is subject to adjustment in accordance with the terms of the agreement. The acquisition is expected to close within three months, subject to customary conditions and regulatory approvals in certain jurisdictions.

### Free Cash Flow

*(In millions)*

|  | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | ---: | ---: |
| Net cash (used in) provided by operating activities | $(6.3) | $4.6 |
| Purchases of property, plant and equipment | (25.2) | (25.3) |
| Purchases of software and other deferred charges | (2.0) | (1.4) |
| Proceeds from sales of property, plant and equipment | .1 | 2.8 |
| Purchases of investments, net | (3.8) | (.4) |
| Free cash flow | $(37.2) | $(19.7) |

Free cash flow in the first three months of 2016 decreased compared to the same period last year primarily due to higher incentive compensation payments and operational working capital, partially offset by higher net income.

### Outlook

Certain factors that we believe may contribute to results for 2016 are described below:

- We expect organic sales growth of 3% to 4.5% and increased earnings.
- Based on currency rates in effect during April 2016, we expect currency translation to reduce net sales by approximately 2% and reduce pre-tax income by approximately $15 million.
- If our acquisition of MACtac closes with expected timing, we anticipate the acquisition will increase full year reported net sales by approximately 1% with an immaterial impact on net income.
- We expect to fund the acquisition of MACtac with cash and existing credit facilities.
- We expect our full year effective tax rate to be in the low to mid-thirty percent range.
- We anticipate capital and software expenditures of approximately $200 million.
- We estimate cash restructuring charges of approximately $25 million.
- We anticipate a one-time non-cash pre-tax charge of approximately $40 million to settle certain U.S. pension obligations, subject to pension asset and liability valuations on the settlement date.

19

### ANALYSIS OF RESULTS OF OPERATIONS FOR THE FIRST QUARTER

### Income Before Taxes

*(In millions, except percentages)*

|  | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | ---: | ---: |
| Net sales | $1,485.5 | $1,528.0 |
| Cost of products sold | 1,062.9 | 1,098.0 |
| Gross profit | 422.6 | 430.0 |
| Marketing, general and administrative expense | 278.2 | 300.4 |
| Interest expense | 15.3 | 15.3 |
| Other expense, net | 5.6 | 14.3 |
| Income before taxes | $123.5 | $100.0 |
| As a Percentage of Sales |  |  |
| Gross profit | 28.4% | 28.1% |

#### Gross Profit Margin

Gross profit margin for the first quarter of 2016 increased compared to the same period last year reflecting benefits from productivity initiatives, including savings from restructuring, net of transition costs, and higher volume, partially offset by geographic mix and higher employee-related costs.

#### Marketing, General and Administrative Expense

Marketing, general and administrative expense decreased in the first quarter of 2016 compared to the same period last year reflecting benefits from productivity initiatives, including savings from restructuring, net of transition costs, and the impact of currency, partially offset by higher employee-related costs.

#### Other Expense, net

*(In millions)*

| Other expense, net by type Restructuring charges: | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | ---: | ---: |
| Severance and related costs | $5.2 | $13.5 |
| Asset impairment charges and lease cancellation costs | .4 | .4 |
| Other items: |  |  |
| Impairment charges on assets held for sale | – | 2.0 |
| Legal settlement | – | (.5) |
| Gain on sale of asset | – | (1.7) |
| Divestiture-related costs | – | .6 |
| Other expense, net | $5.6 | $14.3 |

Refer to Note 9, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding charges associated with restructuring.

### Net Income and Earnings per Share

*(Dollars in millions, except per share amounts)*

|  | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | ---: | ---: |
| Income before taxes | $123.5 | $100.0 |
| Provision for income taxes | 33.9 | 28.1 |
| Net income | $89.6 | $71.9 |
| Net income per common share | $1.00 | $.79 |
| Net income per common share, assuming dilution | .98 | .78 |
| Effective tax rate | 27.4% | 28.1% |

20

#### Provision for Income Taxes

The effective tax rate for the three months ended April 2, 2016 and April 4, 2015 included $2.6 million and $3.3 million, respectively, of a discrete tax benefit due to decreases in certain tax reserves, including interest and penalties, as a result of closing tax years. Additionally, the effective tax rate for the three months ended April 4, 2015 included $1.6 million of a net benefit related to changes in the effective tax rates in certain foreign municipalities.

The effective tax rate for the three months ended April 2, 2016 compared to the same period last year reflects a decrease in tax expense related to favorable changes in the geographic mix of income before taxes and certain tax reserves.

Our effective tax rate can vary widely from quarter to quarter due to interim reporting requirements, the recognition of discrete events, and the timing of repatriation of foreign earnings. Refer to Note 11, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for further information.

### RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE FIRST QUARTER

Operating income refers to income before interest and taxes.

### Pressure-sensitive Materials

*(In millions)*

|  | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $1,108.7 | $1,136.3 |
| Less intersegment sales | (16.7) | (15.7) |
| Net sales | $1,092.0 | $1,120.6 |
| Operating income(1) | 138.5 | 122.9 |
| (1) Included costs associated with restructuring in both quarters and a gain on sale of an asset in 2015. | $2.1 | $5.6 |

#### Net Sales

| Estimated change in sales due to | Three Months Ended April 2, 2016 |
| --- | ---: |
| Organic sales change | 4% |
| Foreign currency translation | (7) |
| Reported sales change | (3)% |

In the first quarter of 2016, sales increased on an organic basis primarily due to higher volume. Sales increased on an organic basis at a high-single digit rate in emerging markets and at low-single digit rates in both North America and Western Europe.

In the first quarter of 2016, sales increased on an organic basis at a mid-single digit rate for the Materials product group and decreased at a mid-single digit rate for the Performance Tapes product group.

#### Operating Income

Operating income increased in the first quarter of 2016 compared to the same period last year due to benefits from productivity initiatives, including savings from restructuring, net of transition costs, and higher volume, partially offset by higher employee-related costs, the unfavorable impact of foreign currency translation, and geographic mix.

### Retail Branding and Information Solutions

*(In millions)*

|  | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $378.7 | $388.7 |
| Less intersegment sales | (.6) | (.6) |
| Net sales | $378.1 | $388.1 |
| Operating income(1) | 26.1 | 19.2 |
| (1) Included costs associated with restructuring in both quarters and impairment charges on assets held for sale, a legal settlement, and divestiture-related costs in 2015. | $3.4 | $5.5 |

#### Net Sales

| Estimated change in sales due to | Three Months Ended April 2, 2016 |
| --- | ---: |
| Organic sales change | 4% |
| Foreign currency translation | (3) |
| Product line divestiture | (4) |
| Reported sales change | (3)% |

In the first quarter of 2016, sales increased on an organic basis primarily due to higher volume, largely related to sales of radio-frequency identification products.

#### Operating Income

Operating income increased in the first quarter of 2016 primarily reflecting benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, and the net impact of volume and product mix, partially offset by higher employee-related costs and the net impact of pricing and raw material input costs.

### Vancive Medical Technologies

*(In millions)*

|  | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | --- | ---: |
| Net sales including intersegment sales | $15.6 | $20.9 |
| Less intersegment sales | (.2) | (1.6) |
| Net sales | $15.4 | $19.3 |
| Operating loss(1) | (.9) | (2.1) |
| (1) Included costs associated with restructuring in both quarters. | $.1 | $1.1 |

#### Net Sales

| Estimated change in sales due to | Three Months Ended April 2, 2016 |
| --- | ---: |
| Organic sales change | (18)% |
| Foreign currency translation | (2) |
| Reported sales change | (20)% |

In the first quarter of 2016, sales decreased on an organic basis primarily due to lower volume.

#### Operating Loss

Operating loss decreased in the first quarter of 2016 compared to the same period last year primarily due to a reduction in operating costs, partially offset by lower volume.

### FINANCIAL CONDITION

### Liquidity

### Cash Flow from Operating Activities

*(In millions)*

|  | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | ---: | ---: |
| Net income | $89.6 | $71.9 |
| Depreciation and amortization | 44.3 | 49.3 |
| Provision for doubtful accounts and sales returns | 11.2 | 14.8 |
| Net losses from asset impairments and sales/disposals of assets | .6 | 1.1 |
| Stock-based compensation | 7.5 | 7.4 |
| Other non-cash expense and loss | 12.8 | 13.6 |
| Changes in assets and liabilities and other adjustments | (172.3) | (153.5) |
| Net cash (used in) provided by operating activities | $(6.3) | $4.6 |

For cash flow purposes, changes in assets and liabilities and other adjustments exclude the impact of foreign currency translation (discussed below in “Analysis of Selected Balance Sheet Accounts”).

During the first three months of 2016, cash flow from operating activities decreased compared to the same period last year primarily due to higher incentive compensation payments and operational working capital, partially offset by higher net income.

### Cash Flow from Investing Activities

*(In millions)*

|  | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | ---: | ---: |
| Purchases of property, plant and equipment | $(25.2) | $(25.3) |
| Purchases of software and other deferred charges | (2.0) | (1.4) |
| Proceeds from sales of property, plant and equipment | .1 | 2.8 |
| Purchases of investments, net | (3.8) | (.4) |
| Net cash used in investing activities | $(30.9) | $(24.3) |

#### Capital and Software Spending

During the first three months of 2016 and 2015, we invested in new equipment to support growth, primarily in Asia, and to improve manufacturing productivity.

### Cash Flow from Financing Activities

*(In millions)*

|  | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | ---: | ---: |
| Net increase in borrowings (maturities of 90 days or less) | $169.4 | $64.2 |
| Payments of debt (maturities longer than 90 days) | (.5) | (.2) |
| Dividends paid | (33.0) | (31.8) |
| Share repurchases | (95.6) | (33.8) |
| Proceeds from exercises of stock options, net | 16.0 | 16.0 |
| Other | (9.2) | (8.4) |
| Net cash provided by financing activities | $47.1 | $6.0 |

#### Borrowings and Repayment of Debt

Given the seasonality of our cash flow, during the first three months of 2016 and 2015, our commercial paper borrowings were used mainly to fund share repurchase activity, dividend payments, and capital expenditures.

#### Dividend Payments

We paid dividends of $.37 per share in the first three months of 2016 compared to $.35 per share in the same period last year. In April 2016, we increased our quarterly dividend to $.41 per share, representing an 11% increase from our previous dividend rate of $.37 per share.

#### Share Repurchases

During the first three months of 2016, we repurchased approximately 1.5 million shares of our common stock at an aggregate cost of $95.6 million. During the first three months of 2015, we repurchased approximately .6 million shares of our common stock at an aggregate cost of $33.8 million.

As of April 2, 2016, approximately $272 million remained authorized for repurchase under our outstanding board authorization.

### Analysis of Selected Balance Sheet Accounts

#### Long-lived Assets

In the three months ended April 2, 2016, goodwill increased by approximately $9 million to $695 million as result of the impact of foreign currency translation.

In the three months ended April 2, 2016, other intangibles resulting from business acquisitions, net, decreased by approximately $5 million to $41 million, which primarily reflected current year amortization expense.

Refer to Note 4, “Goodwill,” to the unaudited Condensed Consolidated Financial Statements for more information.

In the three months ended April 2, 2016, other assets decreased by approximately $10 million to $396 million, which reflected amortization expense related to software and other deferred charges, net of purchases, as well as the impact of foreign currency translation.

#### Shareholders’ Equity Accounts

In the three months ended April 2, 2016, the balance of our shareholders’ equity increased by approximately $3 million to $968 million, which primarily reflected net income, the use of treasury shares to settle exercises of stock options and vesting of stock-based awards and fund contributions to our U.S. defined contribution plan, and the favorable impact of foreign currency translation. These increases were largely offset by share repurchases and dividend payments.

### Impact of Foreign Currency Translation

*(In millions)*

|  | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | ---: | ---: |
| Change in net sales | $(83) | $(106) |
| Change in net income | (6) | (7) |

International operations generated approximately 73% of our net sales during the three months ended April 2, 2016. Our future results are subject to changes in political and economic conditions in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.

The unfavorable impact of foreign currency translation on net sales in the first three months of 2016 compared to the same period last year was primarily related to euro-denominated sales, as well as sales in Brazil.

### Effect of Foreign Currency Transactions

The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the same currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate.

### Analysis of Selected Financial Ratios

We utilize the financial ratios discussed below to assess our financial condition and operating performance.

#### Working Capital and Operational Working Capital Ratios

Working capital (current assets minus current liabilities and net assets held for sale), as a percentage of annualized net sales, improved in the first three months of 2016 compared to the same period last year, primarily due to the decrease in current deferred taxes as a result of the prospective adoption of accounting guidance to classify deferred taxes as non-current in the fourth quarter of 2015. This decrease was partially offset by increases in trade accounts receivable and inventories.

Operational working capital, as a percentage of annualized net sales, is reconciled with working capital below. Our objective is to minimize our investment in operational working capital, as a percentage of annualized net sales, to maximize cash flow and return on investment.

*(Dollars in millions)*

|  | Three Months Ended April 2, 2016 | April 4, 2015 |
| --- | ---: | ---: |
| (A) Working capital | $290.7 | $362.2 |
| Reconciling items: |  |  |
| Cash and cash equivalents | (169.6) | (189.0) |
| Current deferred and refundable income taxes and other current assets | (176.7) | (260.5) |
| Short-term borrowings and current portion of long-term debt and capital leases | 264.9 | 265.7 |
| Current deferred and payable income taxes and other current accrued liabilities | 492.4 | 493.4 |
| (B) Operational working capital | $701.7 | $671.8 |
| (C) Annualized net sales (quarter sales, multiplied by four) | $5,942.0 | $6,112.0 |
| Working capital, as a percentage of annualized net sales (A) ÷ (C) | 4.9% | 5.9% |
| Operational working capital, as a percentage of annualized net sales (B) ÷ (C) | 11.8% | 11.0% |

#### Accounts Receivable Ratio

The average number of days sales outstanding was 63 in the first three months of 2016 compared to 59 in the first three months of 2015. The average number of days outstanding was calculated using the trade accounts receivable balance at quarter-end divided by the average daily sales for the quarter. The increase in the average number of days sales outstanding from the prior year primarily reflected the impact of foreign currency translation and the timing of collections.

#### Inventory Ratio

Average inventory turnover decreased to 8.2 in the first three months of 2016 from 8.6 in the first three months of 2015. The average inventory turnover was calculated using the annualized cost of sales (quarterly cost of sales, multiplied by four) divided by the inventory balance at quarter-end. The decrease in the current year average inventory turnover primarily reflected the impact of foreign currency translation.

#### Accounts Payable Ratio

The average number of days payable outstanding was 72 in the first three months of 2016 compared to 68 in the first three months of 2015. The average number of days payable outstanding was calculated using the accounts payable balance at quarter-end divided by the average daily cost of products sold for the quarter. The increase in average number of days payable outstanding from the prior year primarily reflected the impact of foreign currency translation and the timing of vendor payments.

### Capital Resources

Capital resources include cash flows from operations, cash and cash equivalents and debt financing. At April 2, 2016, we had cash and cash equivalents of $169.6 million held in accounts at third-party financial institutions.

Our cash balances are held in numerous locations throughout the world. At April 2, 2016, the majority of our cash and cash equivalents was held by our foreign subsidiaries.

To meet U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including borrowings from foreign subsidiaries, and repatriating foreign earnings. However, if we were to repatriate incremental foreign earnings, we may be subject to additional taxes in the U.S.

Our Revolver is used as a back-up facility for our commercial paper program and can be used to finance other corporate requirements. The Revolver matures on October 3, 2019. The maturity date may be extended for additional one-year periods under certain circumstances. The commitments under the Revolver may be increased by up to $325 million, subject to lender approval and other customary requirements. As of April 2, 2016, there was no balance outstanding under the Revolver. Refer to Note 5, “Debt and Capital Leases,” to the unaudited Condensed Consolidated Financial Statements for more information.

In March 2016, we entered into an agreement with three commercial paper dealers to establish a Euro-Commercial Paper Program pursuant to which we may issue unsecured commercial paper notes up to a maximum aggregate amount outstanding of $500 million. Proceeds from issuances under this program may be used for general corporate purposes. The maturities of the notes may vary, but may not exceed 364 days from the date of issuance. Our payment obligations with respect to any notes issued under this program are backed by the Revolver. There are no financial covenants under this program. As of April 2, 2016, there were no balances outstanding under this program.

We are exposed to financial market risk resulting from changes in interest and foreign currency rates, and to possible liquidity and credit risks of our counterparties.

In April 2016, we entered into an agreement to acquire MACtac from Platinum Equity for a purchase price of €200 million, including assumed debt. The purchase price is subject to adjustment in accordance with the terms of the agreement. We expect to fund the acquisition of MACtac with cash and existing credit facilities.

#### Capital from Debt

Our total debt increased by approximately $169 million in the first three months of 2016 to $1.23 billion, primarily reflecting an increase in commercial paper borrowings used to fund share repurchase activity, dividend payments, and capital expenditures given the seasonality of our cash flow during the first three months of the year, as well as an increase in short-term borrowings to support operational requirements.

Credit ratings are a significant factor in our ability to raise short- and long-term financing. The credit ratings assigned to us also impact the interest rates paid and our access to commercial paper, credit facilities, and other borrowings. A downgrade of our short-term credit ratings below current levels could impact our ability to access the commercial paper markets. If our access to commercial paper markets were to become limited, the Revolver and our other credit facilities would be available to meet our short-term funding requirements, if necessary. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. We remain committed to maintaining an investment grade rating.

### Off-Balance Sheet Arrangements, Contractual Obligations, and Other Matters

Refer to Note 15, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements.

### RECENT ACCOUNTING REQUIREMENTS

Refer to Note 17, “Recent Accounting Requirements,” to the unaudited Condensed Consolidated Financial Statements.

## Market risk

As filed, 160 characters.

There have been no material changes to the information provided in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended January 2, 2016.

## Controls and procedures

As filed, 2,778 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(f)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgement in evaluating the cost-benefit relationship of possible controls and procedures.

Our disclosure controls system is based upon a global chain of financial and general business reporting lines that converge in our headquarters in Glendale, California. As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such time to provide reasonable assurance that information was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

### Changes in Internal Control Over Financial Reporting

We periodically assess our internal control environment. During 2014, we began a phased implementation of a new transactional system in our RBIS segment that is expected to continue through 2018. Processes affected by this implementation include, among other things, order management, pricing, shipping, general accounting and planning. Where appropriate, we are reviewing related internal controls and making changes. Other than this implementation, there have been no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 161 characters.

There have been no material changes to the risk factors included in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended January 2, 2016.

Filed May 3, 2016.
Source: SEC EDGAR, the filing index for accession 0001104659-16-117169. Last ingested by Listed: Nov 10, 2026, 16:39 ET. No prices; not investment advice.
